Data from A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study
Authors:
- Patrick NevenPatrick Neven
- Nicole StahlNSNicole Stahl
- Maria VidalMVMaria Vidal
- Miguel MartínMMMiguel Martín
- Peter A. KaufmanPKPeter A. Kaufman
- Nadia HarbeckNHNadia Harbeck
- Kelly K. HuntKHKelly K. Hunt
- Stacey CarterSCStacey Carter
- Francois-Clement BidardFBFrancois-Clement Bidard
- Peter A. FaschingPeter A. Fasching
- Philippe AftimosPAPhilippe Aftimos
- Duncan WheatleyDWDuncan Wheatley
Open Access
- 2 December 2024
- other
- Published by American Association for Cancer Research (AACR)